Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitus

Leocadio Rodriguez-Mañas, Olga Laosa, Bruno Vellas, Giuseppe Paolisso, Eva Topinkova, Juan Oliva-Moreno, Isabelle Bourdel-Marchasson, Mikel Izquierdo, Kerry Hood, Andrej Zeyfang, Giovanni Gambassi, Mirko Petrovic, Tim C Hardman, Mark J Kelson, Ivan Bautmans, Gabor Abellan, Michelangela Barbieri, Luz M Peña-Longobardo, Sophie C Regueme, Riccardo Calvani, Stefanie De Buyser, Alan J Sinclair, European MID-Frail Consortium, Leocadio Rodriguez-Mañas, Olga Laosa, Bruno Vellas, Giuseppe Paolisso, Eva Topinkova, Juan Oliva-Moreno, Isabelle Bourdel-Marchasson, Mikel Izquierdo, Kerry Hood, Andrej Zeyfang, Giovanni Gambassi, Mirko Petrovic, Tim C Hardman, Mark J Kelson, Ivan Bautmans, Gabor Abellan, Michelangela Barbieri, Luz M Peña-Longobardo, Sophie C Regueme, Riccardo Calvani, Stefanie De Buyser, Alan J Sinclair, European MID-Frail Consortium

Abstract

Background: Type 2 diabetes, a highly prevalent chronic disease, is associated with increasing frailty and functional decline in older people. We aimed to evaluate the effectiveness of a multimodal intervention on functional performance in frail and pre-frail participants aged ≥70 years with type 2 diabetes mellitus.

Methods: The MID-Frail study was a cluster-randomized multicenter clinical trial conducted in 74 trial sites across seven European countries. The trial recruited 964 participants who were aged >70 years [mean age in intervention group, 78.4 (SD 5.6) years, 49.2% male and 77.6 (SD 5.29) years, 52.4% male in usual care group], with type diabetes mellitus and determined to be frail or pre-frail using Fried's frailty phenotype. Participants were allocated by trial site to follow either usual care (UCG) or intervention procedures (IG). Intervention group participants received a multimodal intervention composed of (i) an individualized and progressive resistance exercise programme for 16 weeks; (ii) a structured diabetes and nutritional educational programme over seven sessions; and (iii) Investigator-linked training to ensure optimal diabetes care. Short Physical Performance Battery (SPPB) scores were used to assess change in functional performance at 12 months between the groups. An analysis of the cost-effectiveness of the intervention was undertaken using the incremental cost-effectiveness ratio (ICER). Secondary outcomes included mortality, hospitalization, institutionalization, quality of life, burden on caregivers, the frequency and severity of hypoglycaemia episodes, and the cost-effectiveness of the intervention.

Results: After 12 months, IG participants had mean SPPB scores 0.85 points higher than those in the UCG (95% CI, 0.44 to 1.26, P < 0.0001). Dropouts were higher in frail participants and in the intervention group, but significant differences in SPPB between treatment groups remained consistent after sensitivity analysis. Estimates suggest a mean saving following intervention of 428.02 EUR (2016) per patient per year, with ICER analysis indicating a consistent benefit of the described health care intervention over usual care. No statistically significant differences between groups were detected in any of the other secondary outcomes.

Conclusions: We have demonstrated that a 12 month structured multimodal intervention programme across several clinical settings in different European countries leads to a clinically relevant and cost-effective improvement in the functional status of older frail and pre-frail participants with type 2 diabetes mellitus.

Keywords: Diabetes; Frailty; Functional status; Multimodal intervention; Older people; Pre-frail; Randomized controlled trial.

© 2019 The Authors Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.

Figures

Figure 1
Figure 1
The MID‐Frail study diagram. *IG, intervention group. †UCG, usual care group.
Figure 2
Figure 2
The ICER considering direct health care costs (EUR 2016) and differences on SPPB.

References

    1. Sinclair AJ, Dunning T, Rodriguez‐Mañas L. Diabetes in older people: new insights and remaining challenges. Lancet Diabetes Endocrinol 2015;3:275–285.
    1. GBD 2015DALYs and HALE collaborators . Global, regional, and national disability‐adjusted life‐years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1603–1658.
    1. Wong E, Backholer K, Gearon E, Harding J, Freak‐Poli R, Stevenson C, et al. Diabetes and risk of physical disability in adults: a systematic review and meta‐analysis. Lancet Diabetes Endocrinol 2013;1:106–114.
    1. Hanlon P, Nicholl BI, Jani BD, Lee D, McQueenie R, Mair FS. Frailty and pre‐frailty in middle‐aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. Lancet Public Health 2018;3:e323–e332.
    1. Castro‐Rodríguez M, Carnicero JA, Garcia‐Garcia FJ, Walter S, Morley JE, Rodríguez‐Artalejo F, et al. Frailty as a major factor in the increased risk of death and disability in older people with diabetes. J Am Med Dir Assoc 2016;17:949–955.
    1. Volpato S, Bianchi L, Lauretani F, Lauretani F, Bandinelli S, Guralnik JM, et al. Role of muscle mass and muscle quality in the association between diabetes and gait speed. Diabetes Care 2012;35:1672–1679.
    1. Sinclair AJ, Abdelhafiz AH, Rodríguez‐Mañas L. Frailty and sarcopenia—newly emerging and high impact complications of diabetes. J Diabetes Complications 2017. Sep;31:1465–1473.
    1. Sinclair A, Morley J. Frailty and diabetes. Lancet 2013;382:1386–1387.
    1. Pahor M, Guralnik JM, Ambrosius WT, Blair S, Bonds DE, Church TS, et al. Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA 2014;311:2387–2396.
    1. Koye DN, Shaw JE, Magliano DJ. Diabetes and disability in older Australians: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetes Res Clin Pract 2017;126:60–67.
    1. Fairhall N, Sherrington C, Kurrle SE, Lord SR, Lockwood K, Howard K, et al. Economic evaluation of a multifactorial, interdisciplinary intervention versus usual care to reduce frailty in frail older people. J Am Med Dir Assoc 2015;16:41–48.
    1. de Vries NM, Staal JB, van der Wees PJ, Adang EMM, Akkermans R, Olde Rikkert MGM, et al. Patient‐centred physical therapy is (cost‐)effective in increasing physical activity and reducing frailty in older adults with mobility problems: a randomized controlled trial with 6 months follow‐up. J Cachexia Sarcopenia Muscle 2016;7:422–435.
    1. Cesari M, Landi F, Vellas B, Bernabei R, Marzetti E. Sarcopenia and physical frailty: two sides of the same coin. Front Aging Neurosc 2014;6:192.
    1. Theou O, Stathokostas L, Roland KP, Jakobi JM, Patterson C, Vandervoort AA, et al. The effectiveness of exercise interventions for the management of frailty: a systematic review. J Aging Res 2011;2011:569194.
    1. Cesari M, Vellas B, Hsu FC, Newman AB, Doss H, King AC, et al. A physical activity intervention to treat the frailty syndrome in older persons—results from the LIFE‐P study. J Gerontol A Biol Sci Med Sci 2015;70:216–222.
    1. Cadore EL, Rodriguez‐Manas L, Sinclair A, Izquierdo M. Effects of different exercise interventions on risk of falls, gait ability and balance in physically frail older adults. A systematic review. Rejuvenation Res 2013;16:105–114.
    1. Cadore EL, Izquierdo M. Exercise interventions in polypathological aging patients that coexist with diabetes mellitus: improving functional status and quality of life. Age (Dord) 2015;37:64.
    1. Geirsdottir OG, Amarson A, Briem K, Ramel A, Jonsson PV, Thorsdottir I. Effect of 12‐week resistance exercise program on body composition, muscle strength, physical function and glucose metabolism in healthy, insulin‐resistant, and diabetic elderly Icelanders. J Geront A Biol Med Sci 2012;67:1259–1265.
    1. Bartali B, Frongillo EA, Bandinelli S, Lauretani F, Semba RD, Fried LP, et al. Low nutrient intake is an essential component of frailty in older persons. J Gerontol A Biol Sci Med Sci 2006;61:589–593.
    1. Semba RD, Bartali B, Zhou J, Blaum C, Ko CW, Fried LP. Low serum micronutrient concentrations predict frailty among older women living in the community. J Gerontol A Biol Sci Med Sci 2006;61:594–599.
    1. Rodríguez‐Mañas L, Bayer AJ, Kelly M, Zeyfang A, Izquierdo M, Laosa O, et al. An evaluation of the effectiveness of a multi‐modal intervention in frail and pre‐frail older people with type 2 diabetes—the MID‐Frail study: study protocol for a randomised controlled trial. Trials 2014;15:34.
    1. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower‐extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995;332:556–562.
    1. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146–M156.
    1. Folstein MF, Folstein SE, McHugh PR. “Mini‐mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
    1. Mahoney FI, Barthel D. Functional evaluation: the Barthel Index. Md State Med J 1965;14:56–61.
    1. Sinclair AJ, Paolisso G, Castro M, Bourdel‐Marchasson I, Gadsby R, Rodriguez‐Mañas L. European Diabetes Working Party for Older People. European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab 2011;37:S27–S38.
    1. Ibañez J, Izquierdo M, Argüelles I, Forga L, Larrión JL, García‐Unciti M, et al. Twice‐weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes. Diabetes Care 2005;28:662–667.
    1. Lawton MP, Brody EM. Assessment of older people: self‐maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–186.
    1. Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ‐5D‐5L compared to the EQ‐5D‐3L across eight patient groups: a multi‐country study. Qual Life Res 2013;22:1717–1727.
    1. Onega LL. Helping those who help others: The Modified Caregiver Strain Index. Am J Nurs 2008;108:69–70.
    1. van Buuren S, Groothuis‐Oudshoorn K. Multivariate imputation by chained equations in R. Journal of Statistical Software 2011;45:1–67, URL .
    1. Kasim A, Xiao ZhiMin, Higgings s, De Troyer E. R package version 1.0.6.
    1. Gregg EW, Cheng YJ, Srinivasan M, Lin J, Geiss LS, Albright AL, et al. Trends in cause‐specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet 2018;391:2430–2440.
    1. Fairhall N, Sherrington C, Cameron ID, Kurrle SE, Lord SR, Lockwood K, et al. A multifactorial intervention for frail older people is more than twice as effective among those who are compliant: complier average causal effect analysis of a randomised trial. J Physiother 2017;63:40–44.
    1. Clegg A, Barber S, Young J, Iliffe S, Forster A. The Home‐based Older People's Exercise (HOPE) trial: a pilot randomised controlled trial of a home‐based exercise intervention for older people with frailty. Age Ageing 2014;43:687–695.
    1. Kwon S, Perera S, Pahor M, Katula JA, King AC, Groessl EJ, et al. What is a meaningful change in physical performance? Findings from a clinical trial in older adults (the LIFE‐P study). J Nutr Health Aging 2009;13:538–544.
    1. Henderson RM, Miller ME, Fielding RA, Gill TM, Glynn NW, Guralnik JM, et al. Maintenance of physical function 1 year after exercise intervention in at‐risk older adults: follow‐up from the LIFE Study. J Gerontol A Biol Sci Med Sci 2018;73:688–694.
    1. Espinoza SE, Jung I, Hazuda H. Frailty transitions in the San Antonio Longitudinal Study of Aging. J Am Geriatr Soc 2012;60:652–660.
    1. Trombetti A, Hars M, Hsu FC, Reid KF, Church TS, Gill TM, et al. Effect of physical activity on frailty: secondary analysis of a randomized controlled trial. Ann Intern Med 2018. Mar 6;168:309–316.
    1. Puffer S, Torgerson D, Watson J. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. BMJ 2003;327:785–789.
    1. Nielsen R, Wiggers H, Thomsen HH, Bovin A, Refsgaard J, Abrahamsen J, et al. Effect of tighter glycemic control on cardiac function, exercise capacity, and muscle strength in heart failure patients with type 2 diabetes: a randomized study. BMJ Open Diabetes Res Care 2016. Apr 29;4:e000202.
    1. Cartee GD. Mechanisms for greater insulin‐stimulated glucose uptake in normal and insulin‐resistant skeletal muscle after acute exercise. Am J Physiol Endocrinol Metab 2015. Dec 15;309:E949–E959.
    1. von Haehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2017. J Cachexia Sarcopenia Muscle 2017; 8:1081–1083.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel